Skip to content

Clinical trials

Phase 3 Obesity trials in Turkey (Türkiye)

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 3 Country / region: Turkey (Türkiye) Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20112
20151
20171
20181
20222
20232
20254
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11
Completed7
Terminated3
Active, not recruiting2
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S13
Eli Lilly and Company4
Sanofi3
Amgen2
AstraZeneca1
Boehringer Ingelheim1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity25
Overweight12
Diabetes Mellitus, Type 24
Nutrition Disorders4
Cardiovascular Diseases2
Heart Failure2
Osteoarthritis, Knee2
Sleep Apnea, Obstructive2
Atherosclerosis1
Colitis, Ulcerative1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.